Skip to main content
. 2020 Nov 17;267(Suppl 1):197–211. doi: 10.1007/s00415-020-10278-8

Table 4.

The estimated prevalences in the general population

Feature Descriptiona Sample sizesb (n) Agec (years) Estimated prevalence (%) Ranged Reliabilitye References
Headache Headache N.O.S.  > 200  > 3 41.1 16–60.2 4 [6062]
Tinnitus Tinnitus N.O.S. 4083–15,445  > 14 18.6 17–20.3 4 [63, 64]
Dizziness Dizziness N.O.S. 1003–3267  > 18 18.5 16.7–24.2 5 [6467]
Hearing loss Any objective hearing loss > 25 dB 3267–7490  > 18 12.9 7.2–16.1 5 [66, 6870]
Otalgia Otalgia not associated with infection or otitis 411  > 25 12.5 1 [71]
Aural fullness Aural fullness not associated with infection 411–866  > 25 12.4 7–17.8 2 [72, 73]
Migraine Migraine (diagnostic criteria)  > 200  > 3 10.5 10–11 4 [6062]
Vertigo Rotational, positional or recurrent vertigo 1003–4869  > 18 8.4 4.9–15.2 4 [64, 65, 74]
Falls Falls without external factors 2394–3267  > 40 5.5 1.5–11.5 5 [64, 66, 67]
CPA tumor (radiology) Cerebellopontine angle tumor on MRI 2000  > 45 0.2 1 [75]
EH (histology) Distension of Reissner’s membrane in vestibule or cochlea 560–703  > 0 14.3 9–19.5 4 [20, 76]

Data were not available

N.O.S. Not otherwise specified

aSymptom and hydrops descriptions. In case of heterogeneous or missing descriptions, the feature was defined as N.O.S

bLower and upper limits of the combined sample sizes

cLower limit of the combined age samples

dRange of the combined prevalences

eThe reliability of the combined results defined by a 5-point scoring system: 5 = high reliability, 1 = low reliability